Curcumin for COVID-19 Pre Exposure Prophylaxis
- Registration Number
- CTRI/2020/07/026820
- Lead Sponsor
- Rohit Walia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
People at risk of SARS-CoV 2 infection ( healthcare professionals , attendants of COVID patients , non COVID patients admitted in hospitals or his risk groups like elderly , cardiovascular patients , diabetes , obesity )
Not having a previous COVID19 diagnosis
Not having experienced COVID19 symptoms since 30 th Jan 2020.
Not having taken any pre-exposure prophylaxis ( HCQ , any other medication or Ayurvedic preparation or food supplement )
Having a negative SARS-CoV 2 test before randomisation
Any chronic infection
Renal failure (CrCl < 60 mL/min/1.73 m2) or need for hemodialysis
Known history of hypersensitivity to the study drug or any of its components
Immune suppressant drugs
Recent vaccination within 2 month
Pregnancy
Primary Immunodeficiency states • Anemia
Leukopenia
Thrombocytopenia
Co morbidities precluding survival required for duration of study follow up
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method